Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis. Reply
- PMID: 31875505
- DOI: 10.1056/NEJMc1915042
Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis. Reply
Comment on
-
Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis.N Engl J Med. 2020 Jan 2;382(1):91. doi: 10.1056/NEJMc1915042. N Engl J Med. 2020. PMID: 31875504 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical